There are 859 resources available
Invited Discussant 138MO and 139MO
Presenter: Raghav Sundar
Session: Mini oral session 2: Gastrointestinal tumours
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mini oral session 2: Gastrointestinal tumours
Resources:
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mini oral session: Breast cancer
Resources:
Webcast
LBA3 - Phase III study of neoadjuvant pembrolizumab or placebo plus chemotherapy followed by adjuvant pembrolizumab or placebo for early-stage triple-negative breast cancer (TNBC): KEYNOTE-522 Korean subgroup analysis
Presenter: Jin-Hee Ahn
Session: Mini oral session: Breast cancer
Resources:
Abstract
Slides
Webcast
LBA6 - A phase II, single arm, open label, Simon two-stage study of pembrolizumab in metastatic HER2-negative breast cancer patients: Evaluation of impact of germline variants in APOBEC3B (AUROR)
Presenter: Gwo Fuang Ho
Session: Mini oral session: Breast cancer
Resources:
Abstract
Slides
Webcast
57MO - First-line (1L) ribociclib (RIB) + endocrine therapy (ET) vs combination chemotherapy (combo CT) in HR+/HER2− advanced breast cancer (ABC): A post hoc analysis of Asian and non-Asian patients (pts) from the phase II RIGHT choice trial
Presenter: Govind Babu Kanakasetty
Session: Mini oral session: Breast cancer
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA3, LBA6 and 57MO
Presenter: Mastura Md Yusof
Session: Mini oral session: Breast cancer
Resources:
Slides
Q&A and discussion
Presenter: All Speakers
Session: Mini oral session: Breast cancer
Resources:
Webcast
Progress in preclinical development of targets and inhibitors
Presenter: Irene Braña
Session: In collaboration with AACR: Targeting the kinome
Resources:
Slides
Webcast
Updates on adjuvant therapy for testicular cancer
Presenter: Jan Oldenburg
Session: Improving outcomes in high-risk genitourinary cancers: Updates on perioperative therapy
Resources:
Slides
Webcast